Effect of the lipopolysaccharide antagonist Planktothrix sp. FP1 cyanobacterial extract on human polymorphonuclear leukocytes

International Immunopharmacology

Volumn 11, Issue 2, 2011, Pages 194-198

  Maio, Ramòna Consuèlo ^a   Cosentino, Marco ^a   Rossetti, Carlo ^a   Molteni, Monica ^a   Lecchini, Sergio ^a   Marino, Franca ^a  

^a UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

Cyanobacterial LPS antagonist; Human polymorphonuclear leukocytes; Interleukin 8; Lipopolysaccharide; Reactive oxygen species; Tumor necrosis factor alpha

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CYANOBACTERIAL LIPOPOLYSACCHARIDE LIKE PRODUCT; FLUORESCENT DYE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; INTERLEUKIN 8; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CELL MIGRATION; CELL STIMULATION; CHEMOTAXIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYANOBACTERIUM; CYTOKINE PRODUCTION; DENSITY GRADIENT CENTRIFUGATION; ENZYME IMMUNOASSAY; ESCHERICHIA COLI; HUMAN; HUMAN CELL; LEUKOCYTE FUNCTION; OSCILLATORIA PLANKTOTHRIX; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; RESPIRATORY BURST; SPECTROPHOTOMETRY; STANDARD; VENOUS BLOOD;

CALCIUM; CELLS, CULTURED; CHEMOTAXIS, LEUKOCYTE; CYANOBACTERIA; HUMANS; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; NEUTROPHILS; REACTIVE OXYGEN SPECIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79151473382     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2010.11.017     Document Type: Article

References (38)

1. R.Y. Stanier, and G. Cohen-Bazire Phototrophic prokaryotes: the cyanobacteria Annu Rev Microbiol 31 1977 225 274
2. C. Romay, N. Ledon, and R. Gonzalez Further studies on anti-inflammatory activity of phycocyanin in some animal models of inflammation Inflamm Res 47 1998 334 338
3. K. Oufdou, N. Mezrioui, B. Oudra, M. Loudiki, M. Barakate, and B. Sbiyyaa Bioactive compounds from Pseudanabaena species (Cyanobacteria) Microbios 106 2001 21 29
4. Q. Shi, J. Cui, J. Zhang, F.X. Kong, Z.C. Hua, and P.P. Shen Expression modulation of multiple cytokines in vivo by cyanobacteria blooms extract from Taihu Lake, China Toxicon 44 2004 871 879
5. E.N. Zainuddin, S. Mundt, U. Wegner, and R. Mentel Cyanobacteria a potential source of antiviral substances against influenza virus Med Microbiol Immunol 191 2002 181 182
6. N. Garbacki, V. Gloaguen, J. Damas, L. Hoffmann, M. Tits, and L. Angenot Inhibition of croton oil-induced oedema in mice ear skin by capsular polysaccharides from cyanobacteria Naunyn Schmied Arch Pharmacol 361 2000 460 464
7. M.R. Prinsep, R.A. Thomson, M.L. West, and B.L. Wylie Tolypodiol, an antiinflammatory diterpenoid from the cyanobacterium Tolypothrix nodosa J Nat Prod 59 1996 786 788
8. T.M. Buttke, and L.O. Ingram Comparison of lipopolysaccharides from Agmenellum quadruplicatum to Escherichia coli and Salmonella typhimurium by using thin-layer chromatography J Bacteriol 124 1975 1566 1573
9. G. Keleti, and J.L. Sykora Production and properties of cyanobacterial endotoxins Appl Environ Microbiol 43 1982 104 109
10. G. Keleti, J.L. Sykora, E.C. Lippy, and M.A. Shapiro Composition and biological properties of lipopolysaccharides isolated from Schizothrix calcicola (Ag.) Gomont (Cyanobacteria) Appl Environ Microbiol 38 1979 471 477
11. Mikheyskaya L.V., Ovodova R.G., and Ovodov Y.S. Isolation and characterization of lipopolysaccharides from cell walls of blue-green algae of the genus Phormidium J Bacteriol 130 1977 1 3
12. J. Weckesser, A. Katz, G. Drews, H. Mayer, and I. Fromme Lipopolysaccharide containing l-acofriose in the filamentous blue-green alga Anabaena variabilis J Bacteriol 120 1974 672 678
13. A. Macagno, M. Molteni, A. Rinaldi, F. Bertoni, A. Lanzavecchia, and C. Rossetti A cyanobacterial LPS antagonist prevents endotoxin shock and blocks sustained TLR4 stimulation required for cytokine expression J Exp Med 203 2006 1481 1492
14. K. Jemmett, A. Macagno, M. Molteni, J.E. Heckels, C. Rossetti, and M. Christodoulides A cyanobacterial lipopolysaccharide antagonist inhibits cytokine production induced by Neisseria meningitidis in a human whole-blood model of septicemia Infect Immun 76 2008 3156 3163
15. E.B. Thorgersen, A. Macagno, C. Rossetti, and T.E. Mollnes Cyanobacterial LPS antagonist (CyP) - a novel and efficient inhibitor of Escherichia coli LPS-induced cytokine response in the pig Mol Immunol 45 2008 3553 3557
16. D. Roos, R. Van Bruggen, and C. Meischl Oxidative killing of microbes by neutrophils Microbes Infect 5 2003 1307 1315
17. V. Witko-Sarsat, P. Rieu, B. Descamps-Latscha, P. Lesavre, and L. Halbwachs-Mecarelli Neutrophils: molecules, functions and pathophysiological aspects Lab Invest 80 2000 617 653
18. H.U. Zeilhofer, and W. Schorr Role of interleukin-8 in neutrophil signaling Curr Opin Hematol 7 2000 178 182
19. T. Kasama, Y. Miwa, T. Isozaki, T. Odai, M. Adachi, and S.L. Kunkel Neutrophil-derived cytokines: potential therapeutic targets in inflammation Curr Drug Targets Inflamm Allergy 4 2005 273 279
20. Y. Kobayashi The role of chemokines in neutrophil biology Front Biosci 13 2008 2400 2407
21. J.C. Alves-Filho, B.M. Tavares-Murta, C. Barja-Fidalgo, C.F. Benjamim, A. Basile-Filho, and S.M. Arraes Neutrophil function in severe sepsis Endocr Metab Immune Disord Drug Targets 6 2006 151 158
22. A.J. Aldridge Role of the neutrophil in septic shock and the adult respiratory distress syndrome Eur J Surg 168 2002 204 214
23. D. Rittirsch, M.A. Flierl, and P.A. Ward Harmful molecular mechanisms in sepsis Nat Rev Immunol 8 2008 776 787
24. E.S. Van Amersfoort, T.J.C. Van Berkel, and J. Kuiper Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock Clin Microbiol Rev 16 2003 379 414
25. L. Xing, and D.G. Remick Relative cytokine and cytokine inhibitor production by mononuclear cells and neutrophils Shock 20 2003 10 16
26. H. Mueller, R. Weingarten, L.A. Ransnas, G.M. Bokoch, and L.A. Sklar Differential amplification of antagonistic receptor pathways in neutrophils J Biol Chem 266 1991 12939 12943
27. E.C. Yi, and M. Hackett Rapid isolation method for lipopolysaccharide and lipid A from gram-negative bacteria Analyst 125 2000 651 656
28. Boyum A. Separation of leukocytes from blood and bone marrow. Introduction Scand J Clin Lab Invest 97 1968 77 89
29. P.C. Wilkinson Micropore filter methods for leukocyte chemotaxis Meth Enzymol 162 1988 38 50
30. Metcalf J.A., Gallin J.I., Nauseef W.M., and Root R. In vitro studies related to diapedesis Laboratory Manual of Neutrophil Function 1986 Raven Press New York 46 67
31. M. Cosentino, F. Marino, S. Cattaneo, L. Di Grazia, C. Francioli, and A.M. Fietta Diazepam-binding inhibitor-derived peptides induce intracellular calcium changes and modulate human neutrophil function J Leuk Biol 67 2000 637 643
32. 2+ indicators with greatly improved fluorescence properties J Biol Chem 260 1985 3440 3450
33. Y. Nagai, S. Akashi, M. Nagafuku, M. Ogata, Y. Iwakura, and S. Akira Essential role of MD-2 in LPS responsiveness and TLR4 distribution Nat Immunol 3 2002 667 672
34. R. Shimazu, S. Akashi, H. Ogata, Y. Nagai, K. Fukudome, and K. Miyake MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4 J Exp Med 189 1999 1777 1782
35. S. Viriyakosol, T. Kirkland, K. Soldau, and P. Tobias MD-2 binds to bacterial lipopolysaccharide J Endotoxin Res 6 2000 489 491
36. W.A. Marasco, S.H. Phan, H. Krutzsch, H.J. Showell, D.E. Feltner, and R. Nairn Purification and identification of formyl-methionyl-leucyl-phenylalanine as the major peptide neutrophil chemotactic factor produced by Escherichia coli J Biol Chem 259 1984 5430 5439
37. Y. Liu, S.K. Shaw, S. Ma, L. Yang, F.W. Luscinskas, and C.A. Parkos Regulation of leukocyte transmigration: cell surface interactions and signaling events Immunol J 172 2004 7 13
38. D. Yang, O. Chertov, and J.J. Oppenheim The role of mammalian antimicrobial peptides and proteins in awakening of innate host defenses and adaptive immunity Cell Mol Life Sci 58 2001 978 989